… Phosphatidylserine is exposed on apoptotic cells and is prone to oxidation (OxPS). Here
we … of IgM antibodies against OxPS (anti-OxPS) with the risk of cardiovascular disease (CVD). …

… Antibodies against cardiolipin and phosphatidylserine (… oxidized CL and PS (OxCL and
OxPS) and phosphorylcholine (anti-PC) could be protection markers for cardiovascular disease (…

… Atherosclerosis is the leading cause of cardiovascular disease (CVD) and is an
inflammatory condition in which activated immune-competent cells, producing mainly pro-inflammatory …

… is an inflammatory disease, and the major cause of cardiovascular disease (CVD) including
… the role of antibodies against oxidized cardiolipin and phosphatidylserine (anti-OxCL and …

… to OxLDL (22) and specifically to oxidized 1-palmitoyl-2-arachidonoyl-… oxidized
phosphatidylserine or phosphatidylethanolamine. Interestingly, E06 bound both to the isolated …

… cardiovascular diseases. When platelets are exposed to oxidative stress, they become
activated. Oxidized LDL (ox-LDL) and metal-catalysed oxidation … cations and phosphatidylserine …

… that undergo oxidation in the context of cardiovascular diseases, both … Oxidized forms of
phosphatidylserine and phosphatidylethanolamine have been described but the most oxidized …

… oxidation products detected in biological samples (tissues and fluids) are likely to be formed
by non-enzymatic reactions, since the oxidized … thus, most oxidized phospholipids detected …

… It has been shown that the accumulation of oxPLs occurs in many diseases, including
cardiovascular disease, atherosclerosis, diabetes and Alzheimer disease (Bochkov et al., 2010; …

… involved in selective phosphatidylserine oxidation in the … asymmetry leading to
phosphatidylserine externalization and … phosphatidylserine signaling in lung physiology and …